Drug intelligence / Profile preview

LBT-6030

Development stage
Preclinical
Lead developer
Longevity Biotech
Modality
Modified Peptides → Peptides
Administration
Oral
01

Overview

LBT-6030 is a dual agonist of the glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors, developed by Longevity Biotech using its proprietary Hybridtide™ platform. This technology utilizes peptidomimetic scaffolds incorporating non-natural amino acids and structural modifications to the molecule's interior, resulting in significantly improved metabolic stability and durability compared to conventional peptide drugs. LBT-6030 is designed to treat metabolic conditions such as obesity and type 2 diabetes by mimicking the synergistic effects of natural incretin hormones on weight loss and glucose regulation. The Hybridtide™ platform allows for tunable affinity between the GLP-1 and GIP receptors, potentially optimizing the therapeutic profile for metabolic disorders.

Other names
Hybridtide GLP-1/GIP dual agonist
02

Targets

GIPR (Gastric inhibitory polypeptide receptor)GLP1R (GLP-1R)

Beyond the preview

Go deeper on LBT-6030.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LBT-6030.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call